Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 95
Filter
1.
BMJ Case Rep ; 17(3)2024 Mar 25.
Article in English | MEDLINE | ID: mdl-38531552

ABSTRACT

Purpura fulminans (PF) is a life-threatening complication of septic shock that can occur due to disseminated infections with Streptococcus pneumoniae The spleen is an important organ in the immunisation process against encapsulated bacteria. Patients with asplenia, either functional or anatomical, are therefore at increased risk of developing serious infections and complications, such as PF, if infected with such bacteria.This case report presents a woman in her late 40s with unacknowledged functional asplenia who was admitted to the hospital with signs of an acute disseminated infection causing septic shock, signs of disseminated intravascular coagulation and infectious PF. A few days after admission, the blood cultures showed growth of S. pneumoniae With early sepsis treatment, the patient survived although with some complications. Clinical presentation, investigations, differential diagnosis, treatment and outcome are presented. Treatment and early recognition of PF are presented and discussed. Relevant recognition and preventative treatment strategies for patients with asplenia are also reviewed and discussed.This case demonstrates the importance of early recognition and treatment of PF in septic patients and the importance of preventive treatment strategies for patients with asplenia to avoid serious infections and complications.


Subject(s)
Bacteremia , Pneumococcal Infections , Purpura Fulminans , Sepsis , Shock, Septic , Splenic Diseases , Female , Humans , Purpura Fulminans/diagnosis , Shock, Septic/complications , Pneumococcal Infections/microbiology , Streptococcus pneumoniae , Sepsis/complications , Bacteremia/complications , Splenic Diseases/complications
2.
Med Klin Intensivmed Notfmed ; 118(8): 646-655, 2023 Nov.
Article in German | MEDLINE | ID: mdl-37466696

ABSTRACT

Febrile seizures, which are relatively common in young children, are often triggered by an infection and resolve quickly. Prompt presentation to a pediatric department is mandatory after any first seizure and every time for children ≤ 12 months. Central nervous system (CNS) diseases in childhood are able to cause seizures or other neurological disorders. Even the slightest suspicion of a seizure with CNS involvement must be promptly treated. In case of doubt, both an antiviral and an antibacterial treatment are started in parallel, which can be stopped after detecting the pathogen. Lumbar puncture is strictly indicated unless there are contraindications. Meningococcal sepsis is a severe clinical feature comprising high fever, chills and disorders of consciousness. The first skin symptoms are petechiae as a red flag sign. With progression, potentially lethal purpura fulminans may develop. Waterhouse-Friderichsen syndrome is a severe complication of acute bacterial meningitis. Lethality rate is 35%. The pediatric assessment triangle and the ABCDE algorithm help to identify critically ill children in a standardized, structured, and rapid manner.


Subject(s)
Meningitis, Bacterial , Purpura Fulminans , Seizures, Febrile , Child , Humans , Infant , Child, Preschool , Seizures, Febrile/diagnosis , Seizures, Febrile/etiology , Seizures, Febrile/therapy , Purpura Fulminans/diagnosis , Purpura Fulminans/therapy , Purpura Fulminans/complications , Emergencies , Meningitis, Bacterial/complications , Meningitis, Bacterial/diagnosis , Meningitis, Bacterial/therapy , Spinal Puncture/adverse effects
4.
Clin Lab ; 69(5)2023 May 01.
Article in English | MEDLINE | ID: mdl-37145086

ABSTRACT

BACKGROUND: Congenital protein C deficiency is a rare hereditary thrombophilia, neonatal purpura fulminans is the most serious form of this deficit. The purpose of this observation is two-fold. The first is the need to make an early diagnosis in order to improve the prognosis. The second, is to discuss the need. In case of extensive purpura fulminans in the neonatal period, the search for a deficiency in anticoagulant factor, in particular the dosage of protein C, in the newborn and in both parents. METHODS: The diagnosis is biological and is based on the quantitative determination of functionally active protein C. We use the Berichrom® Protein C assay on an automated coagulation analyzer from Siemens Healthcare Diagnostics, which allows the chromogenic determination of Protein C activity. RESULTS: We report an observation of cutaneous necrosis in a newborn having developed a purpura fulminans extensive secondary to a total congenital protein C deficiency. In front of this clinical picture, thrombophilia assessment is requested, revealing an isolated deficit in protein C < 1%. CONCLUSIONS: In the case of extensive purpura fulminans in the neonatal period, the search for a deficiency in anticoagulant factor, in particular the dosage of protein C, is essential in the newborn and in both parents.


Subject(s)
Protein C Deficiency , Purpura Fulminans , Thrombophilia , Infant, Newborn , Humans , Purpura Fulminans/diagnosis , Purpura Fulminans/complications , Protein C Deficiency/complications , Protein C Deficiency/diagnosis , Protein C , Thrombophilia/complications , Anticoagulants
5.
Rev Prat ; 73(1): 71-78, 2023 Jan.
Article in French | MEDLINE | ID: mdl-36820463

ABSTRACT

PURPURA FULMINANS IN ADULT PATIENTS. Purpura fulminans is a rare life-threatening infectious disease characterized by the association of a sudden and extensive purpuric rash together with an acute circulatory failure. PF commonly affects young patients with no previous comorbidities. Neisseria meningitidis and Streptococcus pneumoniae are the leading causative bacteria. Diagnosing purpura fulminans before the apparition of the purpuric rash is challenging since prodromal symptoms are nonspecific and consistent with a "flu-like" syndrome. The clinical presentation of patients with purpura fulminans differs from that of patients with bacterial meningitis since most of the patients with purpura fulminans have no neurological impairment. Microbiological diagnosis relies on blood cultures and skin biopsy of purpuric lesions. The indication for lumbar puncture must be evaluated on a case-by-case basis because patients usually have no neurological signs but severe coagulation disorders. Treatment is no different from that of any other septic shock: antibiotic therapy with a third-generation cephalosporin as soon as the diagnosis is suspected and treatment of associated organ failures. Despite these pathogens being highly susceptible to broadly available antibiotics, the prognosis of PF is dismal with a mortality rate of 40% in the intensive care unit and a significant risk of distant sequelae in surviving patients.


PURPURA FULMINANS DE L'ADULTE. Le purpura fulminans (PF) est une maladie infectieuse rare touchant préférentiellement l'adulte jeune sans comorbidités. Il se définit par l'association d'un état de choc septique et d'un purpura d'apparition et d'extension rapides. Les deux principales bactéries responsables sont le méningocoque et le pneumocoque. L'éruption purpurique est précédée par une phase prodromique faite de symptômes aspécifiques (syndrome pseudogrippal) rendant difficile un diagnostic précoce. La présentation clinique des patients ayant un purpura fulminans diffère de celle des patients ayant une méningite bactérienne. Le diagnostic microbiologique repose sur les hémocultures et sur la biopsie cutanée. L'indication de la ponction lombaire est à évaluer au cas par cas car les patients n'ont le plus souvent aucun signe neurologique mais des troubles sévères de l'hémostase contre-indiquant le geste. La prise en charge des patients ayant un PF n'a aucune spécificité comparativement à celle des patients ayant un choc septique lié à une autre porte d'entrée : antibiothérapie par une céphalosporine de troisième génération dès la suspicion diagnostique et traitement des défaillances d'organes associées. Bien que les bactéries responsables de purpura fulminans soient extrêmement sensibles aux antibiotiques, le pronostic du PF reste sombre, avec une mortalité en réanimation s'élevant à 40 % et un risque important de séquelles à distance chez les patients survivants.


Subject(s)
Exanthema , Neisseria meningitidis , Purpura Fulminans , Humans , Adult , Purpura Fulminans/diagnosis , Purpura Fulminans/microbiology , Purpura Fulminans/pathology , Skin/pathology , Anti-Bacterial Agents/therapeutic use
6.
J Burn Care Res ; 44(2): 485-486, 2023 03 02.
Article in English | MEDLINE | ID: mdl-36402743

ABSTRACT

Purpura fulminans (PF) is a life-threatening emergency involving coagulopathy and widespread skin necrosis. Early treatment, especially surgical management, is imperative as prognosis can be very poor. PF is most commonly associated with severe bacterial illness; however, viral causes are also possible. Currently in the literature, there have only been a handful of PF cases associated with COVID-19. We present two cases of PF in the setting of COVID-19 infection. Both patients had a history of underlying coagulopathies. PF can be a sign of underlying coagulopathy in a COVID-19 patient, who is already at increased risk for thromboembolic events due to the inflammatory nature of COVID itself. Due to how quickly PF can develop into life-threatening necrosis and multiorgan failure, it is imperative that these patients are referred early to a burn center for more advanced care.


Subject(s)
Burns , COVID-19 , Purpura Fulminans , Humans , Purpura Fulminans/etiology , Purpura Fulminans/therapy , Purpura Fulminans/diagnosis , COVID-19/complications , Burns/complications , Prognosis , Necrosis
8.
Blood Adv ; 6(2): 495-502, 2022 01 25.
Article in English | MEDLINE | ID: mdl-34788405

ABSTRACT

Idiopathic purpura fulminans (IPF) is a rare but severe prothrombotic coagulation disorder that can occur after chickenpox or human herpesvirus 6 (HHV-6) infection. IPF leads to an autoantibody-mediated decrease in the plasma concentration of protein S. We conducted a retrospective multicenter study involving patients with IPF from 13 French pediatric centers and a systematic review of cases in published literature. Eighteen patients were included in our case series, and 34 patients were included as literature review cases. The median age was 4.9 years, and the diagnostic delay after the first signs of viral infection was 7 days. The lower limbs were involved in 49 patients (94%) with typical lesions. In all, 41 patients (78%) had a recent history of varicella-zoster virus infection, and 7 patients (14%) had been infected by HHV-6. Most of the patients received heparin (n = 51; 98%) and fresh frozen plasma transfusions (n = 41; 79%); other treatment options were immunoglobulin infusion, platelet transfusion, corticosteroid therapy, plasmapheresis, and coagulation regulator concentrate infusion. The antithrombin level and platelet count at diagnosis seemed to be associated with severe complications. Given the rarity of this disease, the creation of a prospective international registry is required to consolidate these findings.


Subject(s)
Chickenpox , Purpura Fulminans , Chickenpox/complications , Child , Child, Preschool , Delayed Diagnosis/adverse effects , Humans , Multicenter Studies as Topic , Prospective Studies , Protein S , Purpura Fulminans/diagnosis , Purpura Fulminans/etiology , Purpura Fulminans/therapy , Retrospective Studies
9.
Arch Pediatr ; 28(6): 488-490, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34246502

ABSTRACT

We report the case of a 7-year-old girl with septic shock and coagulopathy associated with purpura fulminans (PF) and diffuse alveolar hemorrhage (DAH) due to group A Streptococcus (GAS) infection identified with 16S ribosomal RNA analysis performed on the skin biopsy. GAS infection with PF associated with DAH is rare in healthy young children but pediatricians should be aware of this condition because of the poor prognosis. The initial treatment for circulatory failure and severe disseminated intravascular coagulation as well as the prompt initiation of antibiotic treatment may be crucial for the outcomes of S. pyogenes PF.


Subject(s)
Hemorrhage/etiology , Pulmonary Alveoli/abnormalities , Purpura Fulminans/complications , Streptococcal Infections/complications , Anti-Bacterial Agents/therapeutic use , Child , Female , Hemorrhage/physiopathology , Humans , Pulmonary Alveoli/physiopathology , Purpura Fulminans/diagnosis , Streptococcal Infections/diagnosis
11.
BMJ Case Rep ; 14(1)2021 Jan 26.
Article in English | MEDLINE | ID: mdl-33500295

ABSTRACT

A 42-year-old woman with a history of acute myeloid leukaemia status postallogeneic stem cell transplant presented with fevers, altered mental status, pulmonary infiltrates and septic shock that further progressed to thrombocytopenia and purpura fulminans. Laboratory studies were consistent with a diagnosis of thrombotic thrombocytopenic purpura (TTP). Blood cultures grew Streptococcus pneumoniae On chart review, our patient had a history of low immunoglobulin levels following stem cell transplant, which may have predisposed her to pneumococcal infection. The patient responded to therapy with ceftriaxone, plasma exchange, rituximab and caplacizumab. This is the fourth-documented case of pneumococcal induced TTP and, to the best of our knowledge, the first-describing pneumococcal induced TTP with purpura fulminans. We conclude that patients with TTP should be evaluated for infectious aetiologies and empiric antibiotics should be considered. Clinicians should be aware of the possibility for TTP to lead to purpura fulminans.


Subject(s)
Bacteremia/complications , Pneumococcal Infections/complications , Purpura, Thrombotic Thrombocytopenic/etiology , Shock, Septic/complications , Adult , Anti-Bacterial Agents/therapeutic use , Bacteremia/blood , Bacteremia/therapy , Ceftriaxone/therapeutic use , Diagnosis, Differential , Female , Fibrinolytic Agents/therapeutic use , Fingers/pathology , Fingers/surgery , Gangrene , Glucocorticoids/therapeutic use , Graft vs Host Disease/drug therapy , Humans , Immunologic Factors/therapeutic use , Leukemia, Myeloid, Acute/therapy , Nose/pathology , Plasma Exchange , Pneumococcal Infections/blood , Pneumococcal Infections/therapy , Purpura Fulminans/blood , Purpura Fulminans/diagnosis , Purpura, Thrombotic Thrombocytopenic/blood , Purpura, Thrombotic Thrombocytopenic/therapy , Rituximab/therapeutic use , Shock, Septic/blood , Shock, Septic/therapy , Single-Domain Antibodies/therapeutic use , Stem Cell Transplantation , Toes/pathology , Toes/surgery
14.
Korean J Anesthesiol ; 74(3): 266-270, 2021 06.
Article in English | MEDLINE | ID: mdl-32689761

ABSTRACT

BACKGROUND: Pregnancy-related infections are the third most common cause of maternal death worldwide. The aim of this report is to present a case of pregnancy-related infection, which progressed into refractory septic shock accompanied by purpura fulminans and multiple organ failure. CASE: A 23-year-old woman in the postpartum period developed fulminant, refractory septic shock complicated by purpura fulminans and multiple organ failure syndrome (acute respiratory distress syndrome, acute kidney injury, and encephalopathy). Management included antibacterial therapy, fluid and transfusion therapy, nutritional support, protective mechanical ventilation, hydrocortisone, a large dose of ascorbic acid, and thiamine. There were no neurological consequences and all organ functions returned to normal, although the predicted hospital mortality based on the Sequential Organ Failure Assessment (SOFA) score was more than 90%. CONCLUSIONS: Septic shock is a significant, yet not completely understood life-threatening condition, which can be associated with purpura fulminans, multiple organ dysfunction, disseminated intravascular coagulation, and massive tissue necrosis.


Subject(s)
Purpura Fulminans , Shock, Septic , Adult , Anti-Bacterial Agents/therapeutic use , Female , Humans , Multiple Organ Failure/drug therapy , Multiple Organ Failure/therapy , Pregnancy , Purpura Fulminans/diagnosis , Purpura Fulminans/etiology , Purpura Fulminans/therapy , Respiration, Artificial , Shock, Septic/diagnosis , Shock, Septic/etiology , Shock, Septic/therapy , Young Adult
16.
Trop Doct ; 50(4): 330-334, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32998655

ABSTRACT

Acute infectious purpura fulminans is a serious, potentially fatal condition. We present a case series of 11 patients from March 2005 to March 2017, whose clinical symptoms were fever (100%), confusion (63.6%) and headache (55%), and whose common laboratory abnormalities were thrombocytopenia (100%), elevated alkaline phosphatase (70%) and anaemia (63.6%). Three patients (27%) developed gangrene and two presented in shock. Only one grew Neisseria meningitidis in cerebrospinal fluid (CSF) culture and another confirmed by latex agglutination and polymerase chain reaction in CSF. Five others had serology confirmed spotted fever rickettsioses (SFG). All received broad spectrum antibiotics; in 9/11 patients, this included doxycycline or azithromycin. The mean hospital stay was 10.2 days and overall mortality was 18.2%.


Subject(s)
Purpura Fulminans/diagnosis , Purpura Fulminans/therapy , Adult , Anti-Bacterial Agents/therapeutic use , Bacteria/drug effects , Bacteria/isolation & purification , Female , Hospitalization , Humans , India , Male , Middle Aged , Purpura Fulminans/mortality , Purpura Fulminans/pathology , Spotted Fever Group Rickettsiosis/diagnosis , Spotted Fever Group Rickettsiosis/drug therapy , Spotted Fever Group Rickettsiosis/mortality , Spotted Fever Group Rickettsiosis/pathology , Treatment Outcome
20.
J. bras. nefrol ; 41(2): 296-299, Apr.-June 2019. graf
Article in English | LILACS | ID: biblio-1012529

ABSTRACT

ABSTRACT Introduction: Purpura fulminans (PF) is a rapid progressive thrombotic disease in which hemorrhagic infarction of the skin and disseminated intravascular coagulation (DIC) occurs. It can potentially cause acute kidney injury (AKI). However, there is no description in the medical literature of renal histological findings of PF. Case report: A 20-year-old female patient, previously healthy, was admitted to the emergency department (ED) with odynophagia, fever, generalized myalgia and anuria, which evolved with the appearance of purpuric plaques on the face and limbs. She required dialysis on admission. Laboratorial tests showed anemia, leukocytosis, thrombocytopenia, and elevation of lactic dehydrogenase (LDH). The purpuric lesions became bullous with ruptures and then necrotic and erosive, reaching the dermis, subcutaneous tissue and musculature, until bone exposure. There was no improvement with initial antibiotic therapy aimed at the treatment of meningococcemia. Thrombotic microangiopathy (TMA) and PF were then suspected. The patient remained in daily dialysis, requiring plasmapheresis. After sustained improvement of the thrombocytopenia, she underwent renal biopsy, which was not compatible with TMA, characterizing possible PF. A complete recovery of the renal function was achieved and cutaneous sequels were treated with grafts. Conclusion: When thrombotic and hemorrhagic phenomena overlap, obtaining a renal biopsy can be difficult. However, in the presented case, the biopsy allowed the exclusion of AKI caused by TMA, presenting for the first time, histological findings compatible with PF.


RESUMO Introdução: Purpura Fulminans (PF) é uma doença trombótica de rápida progressão, com infarto hemorrágico da pele e coagulação intravascular disseminada (CIVD). É potencialmente causadora de injúria renal aguda (IRA). Porém, não há descrição na literatura médica dos achados histológicos renais causados por PF. Relato de caso: Mulher, 20 anos, previamente hígida, hospitalizada por odinofagia, febre, mialgia generalizada e anúria, evoluiu com aparecimento de placas purpúricas em face e membros. Necessitou de hemodiálise (HD) já na admissão. Exames laboratoriais mostravam anemia, leucocitose, plaquetopenia e elevação de desidrogenase lática. As lesões purpúricas tornaram-se bolhosas com rompimento e progressão para necrose, se aprofundaram, atingindo derme, subcutâneo e musculatura, até a exposição óssea. Não houve melhora com antibioticoterapia inicial voltada para tratamento de meningococemia. Suspeitou-se, então, de microangiopatia trombótica (MAT) e PF. A paciente permaneceu em HD diária e necessitou também de plasmaférese, após melhora sustentada da plaquetopenia, foi submetida à biópsia renal, que não foi compatível com MAT, possivelmente caracterizando PF. Houve recuperação completa da função renal e as sequelas cutâneas foram tratadas com enxerto. Conclusão: Em casos nos quais os fenômenos trombóticos e hemorrágicos se sobrepõem, a obtenção da biópsia renal se torna difícil. Neste caso, a biópsia permitiu excluir IRA causada por MAT e mostrar, pela primeira vez, achados compatíveis com PF.


Subject(s)
Humans , Female , Young Adult , Purpura Fulminans/complications , Purpura Fulminans/diagnosis , Thrombotic Microangiopathies/complications , Thrombotic Microangiopathies/diagnosis , Acute Kidney Injury/complications , Acute Kidney Injury/pathology , Kidney/pathology , Biopsy , Renal Dialysis , Plasmapheresis , Skin Transplantation , Treatment Outcome , Acute Kidney Injury/therapy , Length of Stay
SELECTION OF CITATIONS
SEARCH DETAIL
...